Nahoko Sato

2 articles listing Nahoko Sato in Nature Communications, Science Advances, indexed by Paperzzz from Crossref and OSF.

1. Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study Nature Communications
2. Topoisomerase III-beta protects from immune dysregulation and tumorigenesis Science Advances